IgG4相关肝胆疾病诊疗进展

李萍; 李永哲

doi:10.3969/j.issn.1001-5256.2014.05.003

IgG4相关肝胆疾病诊疗进展

DOI: 10.3969/j.issn.1001-5256.2014.05.003

李萍,
李永哲

北京协和医院风湿免疫科

详细信息

中图分类号: R575
计量
- 文章访问数: 4364
- HTML全文浏览量: 10
- PDF下载量: 905
- 被引次数: 0
出版历程
- 出版日期: 2014-05-20

Progress in diagnosis and treatment of IgG4-related hepatobiliary diseases

Li Ping,
Li YongZhe

摘要

摘要:
IgG4相关性疾病是一类以淋巴浆细胞性炎症为主,伴血清和组织中IgG4增多并累及多器官或组织的慢性进行性全身性炎性疾病,累及肝胆胰腺系统时称之为IgG4相关肝胆疾病。简述了IgG4相关自身免疫性胰腺炎、IgG4相关硬化性胆管炎、IgG4相关自身免疫性肝炎的临床表现和实验室检查等方面。准确识别IgG4相关肝胆疾病的各个实验室结果,并正确诊断此类疾病,有助于避免不必要的手术和错误的治疗。
- 免疫球蛋白G /
- 自身免疫性胰腺炎 /
- 胆管炎,硬化性 /
- 肝炎,自身免疫性 /
- 实验室技术和方法 /
- 综述
Abstract:
IgG4- related diseases are a class of chronic, progressive, systemic inflammatory disorders that are characterized by lymphoplasmacytic inflammation, as well as elevated IgG4 levels in serum and tissue, and may involve multiple organs or tissues. When involving the pancreas, liver, and biliary tracts, they are called IgG4- related hepatobiliary diseases. IgG4- related autoimmune pancreatitis, IgG4- related sclerosing cholangitis, and IgG4- associated autoimmune hepatitis are reviewed in terms of their clinical manifestations and laboratory findings. Accurate identification of the laboratory results for IgG4- related hepatobiliary diseases and correct diagnosis of these diseases help to avoid unnecessary surgery and wrong treatment.
- immunoglobulin G /
- autoimmune pancreatitis /
- cholangitis, sclerosing /
- hepatitis, autoimmune /
- laboratory techniques and proce-dures /
- review

HTML全文

参考文献(37)

[1]KAMISAWA T, FUNATA N, HAYASHI Y, et al.A new clinicopathological entity of IgG4-related autoimmune disease[J].J Gastroenterol, 2003, 38 (10) :982-984.

[2]TAKAHASHI H, YAMAMOTO M, SUZUKI C, et al.The birthday of a new syndrome:IgG4-related diseases constitute a clinical entity[J].Autoimmun Rev, 2010, 9 (9) :591-594.

[3]HAMANO H, KAWA S, HORIUCHI A, et al.High serum IgG4concentrations in patients with sclerosing pancreatitis[J].N Engl J Med, 2001, 344 (10) :732-738.

[4]ZHANG L, SMYRK TC.Autoimmune pancreatitis and IgG4-related systemic diseases[J].Int J Clin Exp Pathol, 2010, 3 (5) :491-504.

[5]FRULLONI L, LUNARDI C, SIMONE R, et al.Identification of a novel antibody associated with autoimmune pancreatitis[J].N Engl J Med, 2009, 361 (22) :2135-2142.

[6]STONE JH, ZEN Y, DESHPANDE V.IgG4-Related Disease[J].N Engl J Med, 2012, 366 (6) :539-551.

[7]SAH RP, CHARI ST.Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis[J].Curr Opin Rheumatol, 2011, 23 (1) :108-113.

[8]KAMISAWA T, SHIMOSEGAWA T, OKAZAKI K, et al.Standard steroid treatment for autoimmune pancreatitis[J].Gut, 2009, 58 (11) :1504-1507.

[9]SARLES H, SARLES JC, MURATORE R, et al.Chronic inflammatory sclerosis of the pancreas—an autonomous pancreatic disease?[J].Am J Dig Dis, 1961, 6 (7) :688-698.

[10]YOSHIDA K, TOKI F, TAKEUCHI T, et al.Chronic pancreatitis caused by an autoimmune abnormality.Proposal of the concept of autoimmune pancreatitis[J].Dig Dis Sci, 1995, 40 (7) :1561-1568.

[11]RYU JK, LEE JK, KIM YT, et al.Clinical features of chronic pancreatitis in Korea:a multicenter nationwide study[J].Digestion, 2005, 72 (4) :207-211.

[12]ZHANG L, CHARI S, SMYRK TC, et al.Autoimmune pancreatitis (AIP) type 1 and type 2:an international consensus study on histopathologic diagnostic criteria[J].Pancreas, 2011, 40 (8) :1172-1179.

[13]SAH RP, CHARI ST, PANNALA R, et al.Differences in clinical profile and relapse rate of type 1 versus type 2 autoimmune pancreatitis pancreatitis[J].Gastroenterology, 2010, 139 (1) :140-148.

[14]KAWA S, HAMANO H.Assessment of serological markers for the diagnosis of autoimmune pancreatitis[J].J Jpn Pancreas Soc, 2003, 17 (1) :607-610.

[15]KAMISAWA T, KIM MH, LIAO WC, et al.Clinical characteristics of 327 Asian patients with autoimmune pancreatitis based on Asian diagnostic criteria[J].Pancreas, 2011, 40 (2) :200-205.

[16]KAMISAWA T, CHARI ST, GIDAY SA, et al.Clinical profile of autoimmune pancreatitis and its histological subtypes:an international multicenter survey[J].Pancreas, 2011, 40 (6) :809-814.

[17]PAIK WH, RYU JK, PARK JM, et al.Clinical and pathological differences between serum immunoglobulin G4-positive and-negative type 1 autoimmune pancreatitis[J].World J Gastroenterol, 2013, 19 (25) :4031-4038.

[18]MATSUBAYASHI H, SAWAI H, KIMURA H, et al.Characteristics of autoimmune pancreatitis based on serum IgG4 level[J].Dig Liver Dis, 2011, 43 (9) :731-735.

[19]FRULLONI L, SCATTOLINI C, FALCONI M, et al.Autoimmune pancreatitis:differences between the focal and diffuse forms in 87patients[J].Am J Gastroenterol, 2009, 104 (9) :2288-2294.

[20]NAITOH I, NAKAZAWA T, OHARA H, et al.Clinical significance of extrapancreatic lesions in autoimmune pancreatitis[J].Pancreas, 2010, 39 (1) :e1-e5.

[21]SHIMOSEGAWA T, CHARI ST, FRULLONI L, et al.International consensus diagnostic criteria for autoimmune pancreatitis:guidelines of the International Association of Pancreatology[J].Pancreas, 2011, 40 (3) :352-358.

[22]OTSUKI M, CHUNG JB, OKAZAKI K, et al.Asian diagnostic criteria for autoimmune pancreatitis:consensus of the Japan-Korea Symposium on Autoimmune Pancreatitis[J].J Gastroenterol, 2008, 43 (6) :403-408.

[23]OKAZAKI K, TOMIYAMA T, MITSUYAMA T, et al.Diagnosis and classification of autoimmune pancreatitis[J].Autoimmun Rev, 2014, 13 (4-5) :451-458.

[24]CHARI ST, TAKAHASHI N, LEVY MJ, et al.A diagnostic strategy to distinguish autoimmune pancreatitis from pancreatic cancer[J].Clin Gastroenterol Hepatol, 2009, 7 (10) :1097-1103.

[25]PICKARTZ T, MAYERLE J, LERCH M.Autoimmune pancreatitis[J].Nat Clin Pract Gastroenterol Hepatol, 2007, 4 (6) :314-323.

[26]GHAZALE A, CHARI ST, ZHANG L, et al.Immunoglobulin G4-associated cholangitis:clinical profile and response to therapy[J].Gastroenterology, 2008, 134 (3) :706-715.

[27]NISHINO T, OYAMA H, HASHIMOTO E, et al.Clinicopathological differentiation between sclerosing cholangitis with autoimmune pancreatitis and primary sclerosing cholangitis[J].J Gastroenterol, 2007, 42 (7) :550-559.

[28]NAKAZAWA T, NAITOH I, HAYASHI K, et al.Diagnostic criteria for IgG4-related sclerosing cholangitis based on cholangiographic classification[J].J Gastroenterol, 2012, 47 (1) :79-87.

[29]OSEINI AM, CHAITEERAKIJ R, SHIRE AM, et al.Utility of serum immunoglobulin G4 in distinguishing immunoglobulin G4-associated cholangitis from cholangiocarcinoma[J].Hepatology, 2011, 54 (3) :940-948.

[30]MENDES FD, JORGENSEN R, KEACH J, et al.Elevated serum IgG4concentration in patients with primary sclerosing cholangitis[J].Am J Gastroenterol, 2006, 101 (9) :2070-2075.

[31]NAKAZAWA T, NAITOH I, HAYASHI K, et al.Diagnosis of IgG4-related sclerosing cholangitis[J].World J Gastroenterol, 2013, 19 (43) :7661-7670.

[32]HIRANO K, TADA M, ISAYAMA H, et al.Endoscopic evaluation of factors contributing to intrapancreatic biliary stricture in autoimmune pancreatitis[J].Gastrointest Endosc, 2010, 71 (1) :85-90.

[33]OHARA H, OKAZAKI K, TSUBOUCHI H, et al.Clinical diagnostic criteria of IgG4-related sclerosing cholangitis 2012[J].J Hepatobiliary Pancreat Sci, 2012, 19 (5) :536-542.

[34]NAITOH I, NAKAZAWA T, OHARA H, et al.Endoscopic transpapillary intraductal ultrasonography and biopsy in the diagnosis of IgG4-related sclerosing cholangitis[J].J Gastroenterol, 2009, 44 (11) :1147-1155.

[35]UMEMURA T, ZEN Y, HAMANO H, et al.Immunoglobin G4-hepatopathy:association of immunoglobin G4-bearing plasma cells in liver with autoimmune pancreatitis[J].Hepatology, 2007, 46 (2) :463-471.

[36]UMEMURA T, ZEN Y, HAMANO H, et al.Clinical significance of immunoglobulin G4-associated autoimmune hepatitis[J].J Gastroenterol, 2011, 46 (Suppl 1) :48-55.

[37]CHUNG H, WATANABE T, KUDO M, et al.Identification and characterization of IgG4-associated autoimmune hepatitis[J].Liver Int, 2010, 30 (2) :222-231.

施引文献

资源附件(0)

访问统计